Delivery Order SPE2DB22D3501-SPE2DB25FXL60
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Victoza 3-Pak 18 mg/3 ml pen injections valued at $7,170.12 under a firm fixed price contract. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025, and represents a non-competitive, non-set-aside delivery order. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Victoza 3-Pak 18 mg/3 ml pen injections, with a ceiling value of $7,126.08. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract was completed on August 19, 2025, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,187.70 to AmerisourceBergen Drug Corp for the supply of Victoza 3-Pak 18 mg/3 ml pen (3 ml), a diabetes medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and an ultimate completion date of August 25, 2025. The contract was executed on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Victoza 3-Pak 18 mg/3 ml pen injections, with a contract ceiling value of $15,763.39. This competitively awarded, non-set-aside delivery order is classified as a firm fixed price contract and is scheduled for completion by September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Victoza 3-Pak 18 mg/3 ml pen medications. The contract carries a ceiling value of $3,945.42 under a firm fixed-price delivery order structure with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, to provide the Victoza 2-Pak 18 mg/3 ml pen medication. The $1,771.72 award has a performance period through January 13, 2023. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $9,848 to Amerisourcebergen Drug Corporation for the supply of 4562286374 VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The contract has a period of performance from September 25, 2023 through September 26, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The order has a potential value of $1,891.09 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- This is a $9,960.34 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for Victoza 3-pak pens, a medication used to treat type 2 diabetes. The delivery order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,182.36 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Victoza 2-pak 18 mg/3 mL pens. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXL60Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,128.38 to AmerisourceBergen Drug Corp for Victoza 3-Pak 18 mg/3 ml pen (3 ml) on September 22, 2025, with an ultimate completion date of September 23, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in fulfilling federal medical procurement requirements through open competition across multiple therapeutic domains. The company serves critical healthcare customers including the Defense Health Agency and U.S. Coast Guard through its extensive contract portfolio with DLA, which includes diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. This delivery order for Victoza, an insulin therapy medication used in diabetes treatment, reflects the company's ongoing role as a primary vendor supporting military and federal healthcare systems through competitively awarded contracts with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/22/25 |